Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 108,400 | 43,400 | 249,700 | 102,000 | 18,900 |
| Depreciation Amortization | 13,500 | 6,200 | 3,000 | 15,600 | 10,100 |
| Income taxes - deferred | -56,900 | -15,600 | -56,700 | -77,300 | -73,100 |
| Accounts receivable | -28,900 | -11,300 | -89,300 | -67,900 | -37,500 |
| Other Working Capital | -117,900 | -31,600 | 28,200 | 81,900 | 35,900 |
| Other Operating Activity | 276,700 | 139,200 | 255,000 | 212,100 | 100,100 |
| Operating Cash Flow | $194,900 | $130,300 | $389,900 | $266,400 | $54,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -511,800 | -320,100 | -1,379,900 | -892,700 | -152,700 |
| PPE Investments | -22,800 | -11,200 | -28,300 | -22,900 | -15,300 |
| Purchase Of Investment | N/A | N/A | -31,300 | -31,300 | N/A |
| Sale Of Investment | 451,400 | 276,300 | 972,400 | 681,600 | N/A |
| Investing Cash Flow | $-83,200 | $-55,000 | $-467,100 | $-265,300 | $-168,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85,700 | 69,900 | 65,300 | 29,900 | 11,100 |
| Other Financing Activity | -308,800 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-223,100 | $69,900 | $65,300 | $29,900 | $11,100 |
| Exchange Rate Effect | 0 | N/A | 300 | N/A | N/A |
| Beginning Cash Position | 259,100 | 259,100 | 270,700 | 270,700 | 270,700 |
| End Cash Position | 147,700 | 404,300 | 259,100 | 301,700 | 168,200 |
| Net Cash Flow | $-111,400 | $145,200 | $-11,600 | $31,000 | $-102,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 194,900 | 130,300 | 389,900 | 266,400 | 54,400 |
| Capital Expenditure | -22,800 | -11,200 | -28,300 | -22,900 | -15,300 |
| Free Cash Flow | 172,100 | 119,100 | 361,600 | 243,500 | 39,100 |